Summary
Foundation Medicine, Inc. (Foundation Medicine), a subsidiary of F. Hoffmann-La Roche Ltd. is a healthcare service provider that offers cancer care services. The company offers molecular information and research services for the discovery of new cancer treatments. Foundation Medicine provides clinical products such as FoundationOne for solid tumors and FoundationOne Heme for hematologic malignancies and sarcomas. It also offers additional materials, services, and real-time data through its technology products such as Interactive Cancer Explorer. The company partners with biotech and pharmaceutical companies to develop targeted cancer therapies and active clinical trials. Foundation Medicine is headquartered in Cambridge, Massachusetts, the US.
Foundation Medicine, Inc. (FMI) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Foundation Medicine, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Foundation Medicine, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Foundation Medicine, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Foundation Medicine, Inc., Medical Equipment, Deal Details 12
Venture Financing 12
Foundation Medicine Raises US$56 Million In Series B Financing 12
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 15
Foundation Medicine Raises US$10 Million In Venture Financing 17
Foundation Medicine Raises US$25 Million In Series A Financing Round 18
Partnerships 19
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Expands Co-Development Agreement With Novartis 25
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 26
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 27
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 28
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 29
Foundation Medicine Extends Co-Development Agreement With Novartis 30
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 31
Foundation Medicine Enters Into An Agreement With Novartis 32
Equity Offering 33
Foundation Medicine Raises USD250 Million in Private Placement of Shares 33
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 35
Foundation Medicine Completes IPO Of Shares For US$122 Million 36
Foundation Medicine, Inc. - Key Competitors 38
Key Employees 39
Locations And Subsidiaries 41
Head Office 41
Other Locations & Subsidiaries 41
Recent Developments 42
Financial Announcements 42
Feb 23, 2016: Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook 42
Nov 03, 2015: Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights 44
Jul 29, 2015: Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights 45
May 11, 2015: Foundation Medicine Announces 2015 First Quarter Results and Recent Highlights 47
Feb 24, 2015: Foundation Medicine Announces 2014 Fourth Quarter and Year-End Results, Recent Highlights 48
Jan 12, 2015: Foundation Medicine Reports Preliminary 2014 Results 49
Corporate Communications 50
Mar 23, 2015: Foundation Medicine Announces Executive Promotions and Expanded Leadership Team to Complement Global Growth Initiatives 50
Mar 23, 2015: Foundation Medicine Announces Proposed Changes to its Board of Directors in Connection with the Pending Roche Transaction 52
Product News 53
Mar 23, 2016: Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne Heme in the Journal Blood 53
Mar 17, 2016: Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016 55
Mar 16, 2016: Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care 57
May 13, 2015: Foundation Medicine's Comprehensive Genomic Profile Informs Therapeutic Choices and Leads to Promising Outcomes in Pediatric Patients With Gliomas 59
Apr 20, 2015: Foundation Medicine Announces Its Collaboration with the National Cancer Institute on Exceptional Responders Initiative 60
Feb 19, 2015: Foundation Medicine to Present New Clinical Data on Clinical Applications of FoundationOne at the 16th Annual Advances in Genome Biology and Technology Meeting 61
Feb 12, 2015: New Data from FoundationOne Demonstrates Genomic Basis for Potential New Routes to Therapy and Improved Outcomes for Individuals with Cancers of Unknown Primary 62
Jan 09, 2015: FoundationOne Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer 64
Jan 08, 2015: Foundation Medicine and Collaborators to Present New Clinical Data on the Application of FoundationOne at the 2015 Gastrointestinal Cancers Symposium 66
Clinical Trials 67
Jan 09, 2015: FoundationOne Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer 67
Other Significant Developments 69
Feb 25, 2016: Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers 69
Nov 02, 2015: Foundation Medicine Announces Roche Pharmaceuticals (Israel) to Commence Commercial Activities in Support of its Molecular Information Products in Oncology 70
Sep 15, 2015: Foundation Medicine Expands Molecular Information Decision Support Offerings with GeneKit, a Genomic Solutions Portal for Pathologists 71
Jan 07, 2015: Foundation Medicine Launches ICE 2, Its New Version of Interactive Cancer Explorer, Featuring PatientMatch 72
Appendix 73
Methodology 73
About GlobalData 73
Contact Us 73
Disclaimer 73
List of Tables
Foundation Medicine, Inc., Medical Equipment, Key Facts, 2015 1
Foundation Medicine, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Foundation Medicine, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Foundation Medicine, Inc., Deals By Market, 2010 to YTD 2016 9
Foundation Medicine, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Foundation Medicine Raises US$56 Million In Series B Financing 12
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 15
Foundation Medicine Raises US$10 Million In Venture Financing 17
Foundation Medicine Raises US$25 Million In Series A Financing Round 18
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Expands Co-Development Agreement With Novartis 25
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 26
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 27
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 28
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 29
Foundation Medicine Extends Co-Development Agreement With Novartis 30
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 31
Foundation Medicine Enters Into An Agreement With Novartis 32
Foundation Medicine Raises USD250 Million in Private Placement of Shares 33
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 35
Foundation Medicine Completes IPO Of Shares For US$122 Million 36
Foundation Medicine, Inc., Key Competitors 38
Foundation Medicine, Inc., Key Employees 39
Foundation Medicine, Inc., Other Locations 41
List of Figures
Foundation Medicine, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Foundation Medicine, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Foundation Medicine, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Foundation Medicine, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Foundation Medicine, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Foundation Medicine, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9
